TECH Bio-Techne Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
17:27
Jul 15
Jul 15
Rotate from overbought tech into financials.
Financials are in an uptrend with many banks hitting three-month highs, while tech appears overbought. This supports rotating out of tech and into financials for the coming months.
MED
11:59
Jun 25
Jun 25
Premarket movers report shows semiconductor stocks surging while hyperscalers decline, along with significant moves in ARS Pharmaceuticals, Bio-Techne, BlackBerry, Dollar Tree, HB Fuller, IBM, Jefferies Financial, Micron Technology, Trip.com ADRs, Qualcomm, and Wendy's.
11:02
Jun 25
Jun 25
Merck KGaA agrees to acquire Bio-Techne Corporation for 11.3 billion dollars in its largest acquisition in over a decade to bolster its life-science business.
09:36
Jun 25
Jun 25
Merck agrees to acquire Bio-Techne for 73 dollars per share in an all-cash deal.
12:52
Jun 15
Jun 15
Activist investor Ananym Capital Management has built a stake in Bio-Techne and is pushing the board to conduct a strategic review that would include a potential sale.
01:57
Apr 17
Apr 17
Tech to lead market gains.
Tech sector will reassert leadership as it facilitates productivity gains, driven by AI, with semiconductors and other areas leading.
HIGH
11:23
Apr 15
Apr 15
Reduce exposure to overowned tech stocks.
After the market rally, it is a good time to reposition and move out of tech because most investors are overweight, making tech likely overowned and prone to underperformance.
MED
23:42
Apr 01
Apr 01
The market summary states the Nasdaq 100 was higher by about 1.2% as people were "taking a bid back into tech companies" on optimism about a potential end to the Iran conflict. A de-escalation in Iran reduces geopolitical risk premiums, favoring growth-oriented sectors like technology. The sector was a highlighted leader in the day's rally. The explicit mention of capital flowing back into tech as a direct response to positive geopolitical developments indicates a clear, positive short-term catalyst for the sector. The Iran conflict does not de-escalate as expected, or other macro headwinds re-emerge.
17:48
Mar 27
Mar 27
The Nasdaq 100 is in a correction, down over 10% from its peak. Tech is getting hit from macro pressures (higher yields, oil) and sector-specific AI disruption fears. Higher oil and rates compound to create a multiple compression environment for growth stocks. The sector is also facing idiosyncratic disruption scares (e.g., AI in cybersecurity, memory chips). In the near term, tech is not a safe haven and is exposed to both macro and micro headwinds. A rapid de-escalation in Iran could bring down oil and yields, relieving the macro pressure. Strong earnings revisions could also provide support.
About TECH Analyst Coverage
Buzzberg tracks TECH (Bio-Techne) across 5 sources. 2 bullish vs 0 bearish calls from 7 analysts. Sentiment: predominantly bullish (22%). 9 total trade ideas tracked. Past 7 days: 1 watch. Latest voices: Victoria Fernandez, zerohedge, Bloomberg.